Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplantAyalew Tefferi,Animesh Pardanani,Kebede H. Begna,Aref Al-Kali,William J. Hogan,Mark R. Litzow,Rhett P. Ketterling,Kaaren K. Reichard,Naseema GangatBLOOD CANCER JOURNAL(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要